Research blog

Dr Nick Cunniffe tells us about his experience as an MS researcher and his hopes for the future of research.

Dr Selinda Orr is an immunologist who specialises in fungal infections. She told us how sharing her work with colleagues in MS research has led to an exciting project.

At ECTRIMS 2023, the world's largest MS research conference, researchers shared ideas about the microbiome and how it could be involved in MS.

In her blog Dr. Charlotte Wicks tells us about her research, using a talking therapy to help people with MS stay in work as long as they'd like.

In her blog, Dr Blanca de Dios Pérez talks about her research into how best to help people with MS stay in work as long as they'd like.

In her blog, Dr Annie Hawton, tells us about her research investigating how well the NHS funding treatment process works for people with MS.

Today is World Brain Day, and this year’s theme is Brain Health and Disability. Professor Gavin Giovannoni heads up the ‘MS Brain Health’ initiative. He’s raising awareness of the importance of brain health to help create a better future for people with MS and their families.

Everyone’s experience of MS is different. People have different symptoms. Some have more relapses or their MS progresses faster. Recent research suggests these differences are influenced by more things than we thought.

We hear from Research Assistants Nimmy Sidhu and Hiba Adan who are working on a new intervention to help people with MS with their fatigue.

Over 2,800,000 people live with MS around the world. And vital research is happening in lots of different countries. Our Director of Research and External Affairs, Dr Sarah Rawlings, tells us about some of the latest happenings on the world MS stage.

Professor Klaus Schmierer leads research into treatments during the diagnostic phase all the way through to advanced MS. We spoke to Klaus to find out why it’s so important for people with MS to be given the choice of disease modifying therapy at every stage of their journey.

Researchers An, Valeria and Simon are thousands of miles apart. But they all share the same goal: to solve the mystery of what causes MS progression.

Dr Emma Gray, our Assistant Director of Research, and Sasha Leigh, who lives with MS, reflect on what research has achieved in recent years.

PhD student Hannah Morris-Bankole and psychologist Dr Laura Allen both live with relapsing remitting MS. They met for the first time and discussed how different therapy styles could be beneficial for people with MS at different times.

Clinical trials are key to finding treatments to slow or stop progression for everyone with MS. We often focus on the drugs being tested, but it’s all the people involved who really make them happen.

Professor Alan Thompson is consultant neurologist at University College London, and past scientific chair of the International Progressive MS Alliance. He’s been researching progressive MS for 40 years. We asked him what’s changed and what’s coming next.

Dr Prince Nwaubani is a psychiatrist, who recently passed his PhD at Brighton and Sussex Medical School. During his PhD, Prince used MRI to investigate the link between brain inflammation and depression in MS.

Associate Professor Rod Middleton leads the UK MS Register. We spoke to Rod to find out what led him there, and what the future of the Register might have in store.

Dr Eleanor Doman is a mathematician, who’s now turning her attention to MS research. We’ve committed to raise funds for her new fellowship project. She tells us how she’s going to use maths to better understand the effects of disease modifying therapies (DMTs) during pregnancy.

Lauren Taylor, a Clinical Psychology PhD student, told us about the NEuRoMS project. It aims to change how cognitive MS symptoms are managed.